Metabolites
Displaying compounds 14126 - 14150 of 16042 in total
| YMDB ID | Name CAS Number | IUPAC Name | Formula Weight | Structure |
|---|---|---|---|---|
| YMDB12624 | CDP-DG(23:1(9Z)/24:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-[(9Z)-tetracos-9-enoyloxy]-3-[(9Z)-tricos-9-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C59H107N3O15P2 1160.459 | |
| YMDB12623 | CDP-DG(23:1(9Z)/24:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-[(11Z)-tetracos-11-enoyloxy]-3-[(9Z)-tricos-9-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C59H107N3O15P2 1160.459 | |
| YMDB12622 | CDP-DG(23:1(9Z)/24:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-(tetracosanoyloxy)-3-[(9Z)-tricos-9-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C59H109N3O15P2 1162.475 | |
| YMDB12621 | CDP-DG(23:1(9Z)/23:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2,3-bis[(9Z)-tricos-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C58H105N3O15P2 1146.432 | |
| YMDB12620 | CDP-DG(23:1(9Z)/23:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-[(11Z)-tricos-11-enoyloxy]-3-[(9Z)-tricos-9-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C58H105N3O15P2 1146.432 | |
| YMDB12619 | CDP-DG(23:1(11Z)/29:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-(nonacosanoyloxy)-3-[(11Z)-tricos-11-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C64H119N3O15P2 1232.61 | |
| YMDB12618 | CDP-DG(23:1(11Z)/27:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(9Z)-heptacos-9-enoyloxy]-3-[(11Z)-tricos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C62H113N3O15P2 1202.54 | |
| YMDB12617 | CDP-DG(23:1(11Z)/27:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(11Z)-heptacos-11-enoyloxy]-3-[(11Z)-tricos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C62H113N3O15P2 1202.54 | |
| YMDB12616 | CDP-DG(23:1(11Z)/27:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-(heptacosanoyloxy)-3-[(11Z)-tricos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C62H115N3O15P2 1204.556 | |
| YMDB12615 | CDP-DG(23:1(11Z)/25:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-[(9Z)-pentacos-9-enoyloxy]-3-[(11Z)-tricos-11-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C60H109N3O15P2 1174.486 | |
| YMDB12614 | CDP-DG(23:1(11Z)/25:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-[(11Z)-pentacos-11-enoyloxy]-3-[(11Z)-tricos-11-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C60H109N3O15P2 1174.486 | |
| YMDB12613 | CDP-DG(23:1(11Z)/25:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-(pentacosanoyloxy)-3-[(11Z)-tricos-11-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C60H111N3O15P2 1176.502 | |
| YMDB12612 | CDP-DG(23:1(11Z)/24:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-[(9Z)-tetracos-9-enoyloxy]-3-[(11Z)-tricos-11-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C59H107N3O15P2 1160.459 | |
| YMDB12611 | CDP-DG(23:1(11Z)/24:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-[(11Z)-tetracos-11-enoyloxy]-3-[(11Z)-tricos-11-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C59H107N3O15P2 1160.459 | |
| YMDB12610 | CDP-DG(23:1(11Z)/24:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-(tetracosanoyloxy)-3-[(11Z)-tricos-11-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C59H109N3O15P2 1162.475 | |
| YMDB12609 | CDP-DG(23:1(11Z)/23:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-[(11Z)-tricos-11-enoyloxy]-2-[(9Z)-tricos-9-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C58H105N3O15P2 1146.432 | |
| YMDB12608 | CDP-DG(23:1(11Z)/23:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2,3-bis[(11Z)-tricos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C58H105N3O15P2 1146.432 | |
| YMDB12607 | CDP-DG(22:1(9Z)/30:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(9Z)-docos-9-enoyloxy]-2-(triacontanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C64H119N3O15P2 1232.61 | |
| YMDB12606 | CDP-DG(22:1(9Z)/28:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(9Z)-docos-9-enoyloxy]-2-[(10Z)-octacos-10-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C62H113N3O15P2 1202.54 | |
| YMDB12605 | CDP-DG(22:1(9Z)/28:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(9Z)-docos-9-enoyloxy]-2-[(12Z)-octacos-12-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C62H113N3O15P2 1202.54 | |
| YMDB12604 | CDP-DG(22:1(9Z)/28:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(9Z)-docos-9-enoyloxy]-2-(octacosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C62H115N3O15P2 1204.556 | |
| YMDB12603 | CDP-DG(22:1(9Z)/26:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(9Z)-docos-9-enoyloxy]-2-[(10Z)-heptacos-10-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C61H111N3O15P2 1188.513 | |
| YMDB12602 | CDP-DG(22:1(9Z)/26:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(9Z)-docos-9-enoyloxy]-2-[(12Z)-hexacos-12-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C60H109N3O15P2 1174.486 | |
| YMDB12601 | CDP-DG(22:1(9Z)/26:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(9Z)-docos-9-enoyloxy]-2-(hexacosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C60H111N3O15P2 1176.502 | |
| YMDB12600 | CDP-DG(22:1(9Z)/25:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(9Z)-docos-9-enoyloxy]-2-[(9Z)-pentacos-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C59H107N3O15P2 1160.459 |